Stockscreener 앱 받기
7.91
1.49%
-0.12
시간 외 거래:
7.90
-0.010
-0.13%
전일 마감가:
$8.03
열려 있는:
$8.04
하루 거래량:
1.22M
Relative Volume:
0.70
시가총액:
$602.59M
수익:
-
순이익/손실:
$-168.09M
주가수익비율:
-3.6452
EPS:
-2.17
순현금흐름:
$-138.01M
1주 성능:
-0.88%
1개월 성능:
-9.18%
6개월 성능:
-61.99%
1년 성능:
-60.72%
1일 변동 폭
$7.91
$8.286
1주일 범위
$7.52
$8.286
52주 변동 폭
$6.98
$24.17
Kura Oncology Inc Stock (KURA) Company Profile
명칭
Kura Oncology Inc
전화
(858) 500-8800
주소
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
KURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
7.91 | 602.59M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-22 | 개시 | Mizuho | Buy |
| 2023-08-11 | 개시 | BofA Securities | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Perform |
| 2023-05-17 | 개시 | BTIG Research | Buy |
| 2023-01-31 | 개시 | Stifel | Buy |
| 2022-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-02-15 | 개시 | Jefferies | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-11-05 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 개시 | Credit Suisse | Outperform |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2018-11-09 | 개시 | Piper Jaffray | Overweight |
| 2018-08-01 | 개시 | H.C. Wainwright | Buy |
| 2016-10-13 | 재개 | Leerink Partners | Outperform |
| 2016-01-22 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-30 | 개시 | Oppenheimer | Outperform |
| 2015-12-16 | 개시 | Citigroup | Buy |
모두보기
Kura Oncology Inc 주식(KURA)의 최신 뉴스
Kura Oncology, Inc. (NASDAQ:KURA) COO Kathleen Ford Sells 1,817 Shares - MarketBeat
Kura Oncology, Inc. (NASDAQ:KURA) Insider Sells $39,058.81 in Stock - MarketBeat
Insider Selling: Kura Oncology, Inc. (NASDAQ:KURA) SVP Sells 4,949 Shares of Stock - MarketBeat
Moody Aldrich Partners LLC Acquires 42,712 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
Kura Oncology's chief legal officer sells $57,315 in stock - MSN
Kura Oncology COO Kathleen Ford sells $14,303 in stock - MSN
Kura Oncology's chief scientific officer sells $17,050 in stock - MSN
Kura Oncology's finance SVP sells shares worth $38,958 - MSN
Kura Oncology's chief legal officer sells $57,315 in stock By Investing.com - Investing.com South Africa
Kura Oncology chief commercial officer sells shares valued at $12,461 By Investing.com - Investing.com Australia
Kura Oncology's chief scientific officer sells $17,050 in stock By Investing.com - Investing.com Canada
Kura Oncology's chief medical officer sells shares worth $39,068 By Investing.com - Investing.com Canada
Kura Oncology's chief medical officer sells shares worth $39,068 - Investing.com India
Kura Oncology chief commercial officer sells shares valued at $12,461 - MSN
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Kura Oncology: Sentiment Is Too Negative (NASDAQ:KURA) - Seeking Alpha
Analysts Set Expectations for Kura Oncology FY2025 Earnings - MarketBeat
Assenagon Asset Management S.A. Sells 146,879 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 17.4% in December - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Harbor Capital Advisors Inc. Boosts Holdings in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology secures new headquarters in San Diego - Investing.com India
Kura Oncology secures new headquarters in San Diego By Investing.com - Investing.com Australia
Kura Oncology stock hits 52-week low at $8.38 amid market challenges - Investing.com Nigeria
Kura Oncology (NASDAQ:KURA) Sets New 12-Month LowTime to Sell? - MarketBeat
Brokers Set Expectations for Kura Oncology FY2029 Earnings - Defense World
Brokers Offer Predictions for Kura Oncology FY2029 Earnings - MarketBeat
BlackRock, Inc. Increases Stake in Kura Oncology Inc - GuruFocus.com
Long Term Trading Analysis for (KURA) - Stock Traders Daily
Scotiabank Cuts Kura Oncology (NASDAQ:KURA) Price Target to $10.00 - MarketBeat
Kura Oncology announces executive changes and settlement By Investing.com - Investing.com Australia
Kura Oncology announces executive changes and settlement - Investing.com India
Kura Oncology appoints new CMO and CSO By Investing.com - Investing.com Australia
Kura Oncology (NASDAQ:KURA) Sets New 1-Year LowTime to Sell? - MarketBeat
Kura Oncology Announces Leadership Changes and Appointments - MSN
Kura Oncology Announces Senior Executive Promotions - The Manila Times
Kura Oncology Promotes New Chief Medical Officer - MarketWatch
Kura Oncology Inc (KURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.95%
2.39%
자본화:
|
볼륨(24시간):